Medical Innovation Exchange

Magenta halts high-dose group in leukemia trial after serious adverse events

https://www.fiercebiotech.com/biotech/magenta-halts-high-dose-group-leukemia-trial-after-serious-adverse-events

Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!